Sebas Daniël Pronk

Title: Sebas Daniël Pronk - Innovator in Binding Molecules

Introduction

Sebas Daniël Pronk is an inventor based in Utrecht, Netherlands. He is currently associated with Linxis B.V. Although he has not yet been granted any patents, his work focuses on innovative binding molecules that target specific receptors involved in cell proliferation and differentiation.

Latest Patent Applications

Sebas Daniël Pronk's notable patent application is titled "Internalizing Binding Molecules Targeting Receptors Involved in Cell Proliferation or in Cell Differentiation." This invention pertains to binding molecules that include at least one single variable antibody domain, specifically aimed at receptors found on myofibroblasts and hepatic stellate cells (HSCs). The application also discusses binding molecules that consist of at least two single variable antibody domains, each targeting a receptor on HSCs and/or myofibroblasts. Furthermore, it covers nucleic acids that encode these binding molecules, host cells for their expression, and methods for their preparation. The invention also includes pharmaceutical compositions containing these binding molecules and their applications for prophylactic, therapeutic, or diagnostic purposes.

Conclusion

Sebas Daniël Pronk is making significant strides in the field of binding molecules, with a focus on innovative applications that could have important implications in medical science. His work, although not yet patented, showcases the potential for future advancements in therapeutic and diagnostic methods.